Log in to save to my catalogue

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67005176

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

The first phase 2 gene therapy trial for HIV-1 has shown some promising signs. There's a long way to go before this would be a viable approach in people with HIV—this trial did not show a statistically significant difference in viral load at the primary end point–but other analyses did reveal that the gene therapy seemed to have a modest, but stati...

Alternative Titles

Full title

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_67005176

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67005176

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/nm.1932

How to access this item